Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
25
SYRS Quote, Financials, Valuation and Earnings
Last price:
$0.21
Seasonality move
:
5.18%
Day range:
$0.20 - $0.22
52-week range:
$0.18 - $8.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
8.06x
Volume:
2.8M
Avg. volume:
17.6M
1-year change:
-96.23%
Market cap:
$5.5M
Revenue:
$9.9M
EPS (TTM):
-$3.07
SYRS Analysts' Consensus Rating
The 0 analysts providing 12-month price projections for Syros Pharmaceuticals shares anticipate an average target of --, ranging from a low estimate of -- to a high estimate of --. This average target implies a growth of 387.33% compared to the current stock price of $0.21.
Consensus Price Target
--
Highest Price Target
--
Lowest Price Target
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 0 | 0 |
| Hold | 0 | 4 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Buy |
SYRS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
